×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
This workshop will be conducted in Japanese Language only.
View the Flyer in Japanese
Program Committee
-
Kentaro Kogushi, PhD Head of Clinical Development Neurology-Psychiatry, Japan Development
AbbVie GK, Japan -
Toshihiko Aranishi, PhD Research Scientist, Health Outcomes/Health Technology Assessment
Eli Lilly Japan K.K, Japan -
Shinzo Hiroi, PhD, MPH, RPh, PMP Head of Global Medical Affairs
Shionogi & Co., Ltd., Japan -
Yusuke Nakamura, MBA, MPH Pharmaceuticals Division, Market Acccess
Bayer Yakuhin, Ltd., Japan -
Shinya Ohno, PhD, MPH Director, HTA Strategy Professional
Chugai Pharmaceutical Co., Ltd, Japan -
Akihito Uda, MPH HEOR Group, Market Access and Public Affairs Division
Novartis Pharma K.K., Japan -
Hisashi Urushihara, DrPH Professor, Faculty of Pharmacy, Department of Pharmacy
Keio University, Japan -
Manami Yoshida, DVM Associate Director, Medical Affairs – HIV & COVID-19
Gilead Sciences K.K., Japan
Have an account?